John R. Johnson, Yang-Min Ning, Ann Farrell, Robert Justice, Patricia Keegan and Richard Pazdur Abstract We reviewed the regulatory history of the accelerated approval process and the US Food and Drug Administration (FDA) experience with accelerated approval of oncology products from its initiation in December 11, 1992, to July 1, 2010. The accelerated approval regulations […]